ABC · updated 2026-08-27

FDA Approves New Pancreatic Cancer Drug

See how ABC are framing this — we run every side, so you decide. News for humans, not bots: serious, civil discussion among real people, with the context and facts you need. Don't just watch: be on the air with your own video takes, polls and predictions.

ABC

“FDA APPROVES NEW PANCREATIC CANCER DRUG”

covered 2026-08-27 ▶ Be on the air with ABC

Watch the moment

PBS NewsHour

CBS Boston

CBS 8 San Diego

Add your voice

Polls, predictions & fact-checks we ran live across networks — your take joins the running tally, compared across every network.

This storyWhat type of cancer did the FDA approves a new drug to treat?

  • Late-stage pancreatic cancer 0%
  • Early-stage lung cancer 0%
  • Metastatic breast cancer 0%
  • Advanced colorectal cancer 0%

Be the first to weigh in

What cancer game-changer drug was approved by the FDA in 2023?

Pancreatic cancer has a 5-year survival rate of only about 13%

FDA approval and a CDC recommendation are two separate steps!

The FDA rules a treatment safe & effective after clinical trials. Then the CDC's ACIP separately votes on who should receive it. And '95% efficacy' means 95% fewer cases vs. placebo — not blanket protection.

The conversation

No comments yet — be the first to add your voice when you're on the air. Civil, moderated, bot-free.

LIVE ROOMS Rooms open during live coverage 1 channel ▾
ABC ▶ Be on the air